Interaction between intravenous immunoglobulin (IVIg) and the low-density lipoprotein receptor-related protein 1: A role for transcytosis across the blood brain barrier?

Journal of Neuroimmunology

Volumn 251, Issue 1-2, 2012, Pages 39-44

  Proulx, Dominic Paquin ^a,b   Rouleau, Pascal ^a   Paré, Isabelle ^a   Vallières Noël, Marie Michelle ^a,b   Bazin, Renée ^a,b  

^a Héma Québec ^*  (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

Author keywords

Endocytosis; Intravenous immunoglobulin; IVIg; LRP1

Indexed keywords

HUMAN IMMUNOGLOBULIN; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN;

ANIMAL CELL; ARTICLE; BLOOD BRAIN BARRIER; CONTROLLED STUDY; DRUG TRANSPORT; ENDOCYTOSIS; INTERNALIZATION; MOLECULAR INTERACTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; TRANSCYTOSIS;

ANIMALS; BIOLOGICAL TRANSPORT; BLOOD-BRAIN BARRIER; CELL LINE; IMMUNOGLOBULINS, INTRAVENOUS; MICE; PHOSPHORYLATION; RECEPTORS, LDL; TRANSCYTOSIS; TUMOR SUPPRESSOR PROTEINS; TYROSINE;

EID: 84865642422     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2012.06.009     Document Type: Article

References (32)

1. Arumugam T.V., Tang S.C., Lathia J.D., Cheng A., Mughal M.R., Chigurupati S., Magnus T., Chan S.L., Jo D.G., Ouyang X., Fairlie D.P., Granger D.N., Vortmeyer A., Basta M., Mattson M.P. Intravenous immunoglobulin (IVIG) protects the brain against experimental stroke by preventing complement-mediated neuronal cell death. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:14104-14109.
2. Bard F., Cannon C., Barbour R., Burke R.L., Games D., Grajeda H., Guido T., Hu K., Huang J., Johnson-Wood K., Khan K., Kholodenko D., Lee M., Lieberburg I., Motter R., Nguyen M., Soriano F., Vasquez N., Weiss K., Welch B., Seubert P., Schenk D., Yednock T. Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease. Nat. Med. 2000, 6:916-919.
3. Betts G.N., van der Geer P., Komives E.A. Structural and functional consequences of tyrosine phosphorylation in the LRP1 cytoplasmic domain. J. Biol. Chem. 2008, 283:15656-15664.
4. Boucher P., Gotthardt M., Li W.P., Anderson R.G., Herz J. LRP: role in vascular wall integrity and protection from atherosclerosis. Science 2003, 300:329-332.
5. Campana W.M., Li X., Dragojlovic N., Janes J., Gaultier A., Gonias S.L. The low-density lipoprotein receptor-related protein is a pro-survival receptor in Schwann cells: possible implications in peripheral nerve injury. J. Neurosci. 2006, 26:11197-11207.
6. Dehouck B., Fenart L., Dehouck M.P., Pierce A., Torpier G., Cecchelli R. A new function for the LDL receptor: transcytosis of LDL across the blood-brain barrier. J. Cell Biol. 1997, 138:877-889.
7. Dodel R.C., Du Y., Depboylu C., Hampel H., Frolich L., Haag A., Hemmeter U., Paulsen S., Teipel S.J., Brettschneider S., Spottke A., Nolker C., Moller H.J., Wei X., Farlow M., Sommer N., Oertel W.H. Intravenous immunoglobulins containing antibodies against beta-amyloid for the treatment of Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry 2004, 75:1472-1474.
8. Duffy K.R., Pardridge W.M. Blood-brain barrier transcytosis of insulin in developing rabbits. Brain Res. 1987, 420:32-38.
9. Fillebeen C., Descamps L., Dehouck M.P., Fenart L., Benaissa M., Spik G., Cecchelli R., Pierce A. Receptor-mediated transcytosis of lactoferrin through the blood-brain barrier. J. Biol. Chem. 1999, 274:7011-7017.
10. Fillit H., Hess G., Hill J., Bonnet P., Toso C. IV immunoglobulin is associated with a reduced risk of Alzheimer disease and related disorders. Neurology 2009, 73:180-185.
11. Fuentealba R.A., Liu Q., Kanekiyo T., Zhang J., Bu G. Low-density lipoprotein receptor-related protein 1 (LRP1) promotes anti-apoptotic signaling in neurons by activating AKT survival pathway. J. Biol. Chem. 2009, 284:34045-34053.
12. Herz J., Strickland D.K. LRP: a multifunctional scavenger and signaling receptor. J. Clin. Invest. 2001, 108:779-784.
13. Herz J., Kowal R.C., Ho Y.K., Brown M.S., Goldstein J.L. Low density lipoprotein receptor-related protein mediates endocytosis of monoclonal antibodies in cultured cells and rabbit liver. J. Biol. Chem. 1990, 265:21355-21362.
14. Hughes R.A., Dalakas M.C., Cornblath D.R., Latov N., Weksler M.E., Relkin N. Clinical applications of intravenous immunoglobulins in neurology. Clin. Exp. Immunol. 2009, 158(Suppl. 1):34-42.
15. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227:680-685.
16. Magga J., Puli L., Pihlaja R., Kanninen K., Neulamaa S., Malm T., Hartig W., Grosche J., Goldsteins G., Tanila H., Koistinaho J., Koistinaho M. Human intravenous immunoglobulin provides protection against Abeta toxicity by multiple mechanisms in a mouse model of Alzheimer's disease. J. Neuroinflammation 2010, 7:90.
17. McCarthy K.M., Yoong Y., Simister N.E. Bidirectional transcytosis of IgG by the rat neonatal Fc receptor expressed in a rat kidney cell line: a system to study protein transport across epithelia. J. Cell Sci. 2000, 113(Pt 7):1277-1285.
18. Moos T., Morgan E.H. Transferrin and transferrin receptor function in brain barrier systems. Cell. Mol. Neurobiol. 2000, 20:77-95.
19. Pan W., Kastin A.J., Zankel T.C., van Kerkhof P., Terasaki T., Bu G. Efficient transfer of receptor-associated protein (RAP) across the blood-brain barrier. J. Cell Sci. 2004, 117:5071-5078.
20. Pardridge W.M., Eisenberg J., Yang J. Human blood-brain barrier transferrin receptor. Metabolism 1987, 36:892-895.
21. Proulx D.P., Aubin E., Lemieux R., Bazin R. Spontaneous internalization of IVIg in activated B cells. Immunol. Lett. 2009, 124:18-26.
22. Ranganathan S., Liu C.X., Migliorini M.M., Von Arnim C.A., Peltan I.D., Mikhailenko I., Hyman B.T., Strickland D.K. Serine and threonine phosphorylation of the low density lipoprotein receptor-related protein by protein kinase Calpha regulates endocytosis and association with adaptor molecules. J. Biol. Chem. 2004, 279:40536-40544.
23. Relkin N.R., Szabo P., Adamiak B., Burgut T., Monthe C., Lent R.W., Younkin S., Younkin L., Schiff R., Weksler M.E. 18-Month study of intravenous immunoglobulin for treatment of mild Alzheimer disease. Neurobiol. Aging 2009, 30:1728-1736.
24. Rubin L.L., Staddon J.M. The cell biology of the blood-brain barrier. Annu. Rev. Neurosci. 1999, 22:11-28.
25. Schlachetzki F., Zhu C., Pardridge W.M. Expression of the neonatal Fc receptor (FcRn) at the blood-brain barrier. J. Neurochem. 2002, 81:203-206.
26. Tselis A., Perumal J., Caon C., Hreha S., Ching W., Din M., Van Stavern G., Khan O. Treatment of corticosteroid refractory optic neuritis in multiple sclerosis patients with intravenous immunoglobulin. Eur. J. Neurol. 2008, 15:1163-1167.
27. Vrethem M., Henriksson A., Malm C., Olsson T., Ernerudh J. Ig-secreting cells pass the blood-brain barrier: studies on kappa and lambda light chain secreting cells in plasma cell dyscrasia. J. Neuroimmunol. 1992, 41:189-194.
28. Wolf B.B., Lopes M.B., VandenBerg S.R., Gonias S.L. Characterization and immunohistochemical localization of alpha 2-macroglobulin receptor (low-density lipoprotein receptor-related protein) in human brain. Am. J. Pathol. 1992, 141:37-42.
29. Wurster U., Haas J. Passage of intravenous immunoglobulin and interaction with the CNS. J. Neurol. Neurosurg. Psychiatry 1994, 57:21-25. (Suppl.).
30. Yamada K., Hashimoto T., Yabuki C., Nagae Y., Tachikawa M., Strickland D.K., Liu Q., Bu G., Basak J.M., Holtzman D.M., Ohtsuki S., Terasaki T., Iwatsubo T. The low density lipoprotein receptor-related protein 1 mediates uptake of amyloid beta peptides in an in vitro model of the blood-brain barrier cells. J. Biol. Chem. 2008, 283:34554-34562.
31. Yang M., Huang H., Li J., Li D., Wang H. Tyrosine phosphorylation of the LDL receptor-related protein (LRP) and activation of the ERK pathway are required for connective tissue growth factor to potentiate myofibroblast differentiation. FASEB J. 2004, 18:1920-1921.
32. Zemskov E.A., Mikhailenko I., Strickland D.K., Belkin A.M. Cell-surface transglutaminase undergoes internalization and lysosomal degradation: an essential role for LRP1. J. Cell Sci. 2007, 120:3188-3199.